Lexeo Therapeutics公司宣布,其Sunrise-Fa 2项目的启动工作正按计划稳步推进,目标是在2026年第二季度内完成。公司预计,首例患者将在今年六月底前入组。
Lexeo Therapeutics公司宣布,其Sunrise-Fa 2项目的启动工作正按计划稳步推进,目标是在2026年第二季度内完成。公司预计,首例患者将在今年六月底前入组。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.